Viewing Study NCT02465957


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-01-04 @ 4:37 PM
Study NCT ID: NCT02465957
Status: TERMINATED
Last Update Posted: 2024-05-02
First Post: 2015-06-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
Sponsor: ImmunityBio, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-09-24
Start Date Type: ACTUAL
Primary Completion Date: 2018-03-19
Primary Completion Date Type: ACTUAL
Completion Date: 2018-03-19
Completion Date Type: ACTUAL
First Submit Date: 2015-06-03
First Submit QC Date: None
Study First Post Date: 2015-06-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-03-20
Results First Submit QC Date: None
Results First Post Date: 2024-05-02
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-01
Last Update Post Date: 2024-05-02
Last Update Post Date Type: ACTUAL